相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF
A. D'Addio et al.
BONE MARROW TRANSPLANTATION (2011)
Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data
R. F. Duarte et al.
BONE MARROW TRANSPLANTATION (2011)
A Pharmacokinetic Study of Plerixafor in Subjects with Varying Degrees of Renal Impairment
Ronald MacFarland et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Meeting the Unmet Needs in Anticoagulant Therapy
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens
Shaji Kumar et al.
BLOOD (2009)
AMD3100 plus G-CSF can successfully mobilize CD34+cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data
G. Calandra et al.
BONE MARROW TRANSPLANTATION (2008)
Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers
R Goterris et al.
BONE MARROW TRANSPLANTATION (2005)
Autologous stem cell transplantation in multiple myeloma: outcome in patients with renal failure
LM Knudsen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant
CK Lee et al.
BONE MARROW TRANSPLANTATION (2004)
Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost
S Boeve et al.
BONE MARROW TRANSPLANTATION (2004)
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma
JA Child et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation
U Narayanasami et al.
BLOOD (2001)
Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers
CW Hendrix et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Myopericarditis caused by cyclophosphamide used to mobilize peripheral blood stem cells in a myeloma patient with renal failure
R Yamamoto et al.
BONE MARROW TRANSPLANTATION (2000)